1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001) : an open-label, non-inferiority, randomised controlled trial
(
- Contribution to journal › Article
- 2012
-
Mark
Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidney
(
- Contribution to journal › Article
- 2011
-
Mark
Prognostic Value of PAX-FKHR Fusion Status in Alveolar Rhabdomyosarcoma: A Report From the Cooperative Soft Tissue Sarcoma Study Group (CWS)
(
- Contribution to journal › Article
- 2008
-
Mark
Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma
(
- Contribution to journal › Article
- 2007
-
Mark
Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdomyosarcoma in children
(
- Contribution to journal › Article